JavaScript is disabled in your browser. Please enable JavaScript to view this website.

BDNF (BDNF)

BDNF protein structure

Image 1: BDNF protein structure.

BDNF Target Introduction

Protein Function

Protein Expression

Protein Localization

ICC experimental result image of BDNF target, using the Anti-BDNF antibody [EPR1292] (ab108319)

Image 2: ICC experimental result image of BDNF target, using the Anti-BDNF antibody [EPR1292] (ab108319). Green: BDNF, Red: Tubulin, Blue: DAPI.

Isoforms & post-translational modifications

WB experiment tips

Precautions

Positive control

Example of results

WB-Anti-BDNF antibody [EPR1292] (ab108319)

Figure 3: WB-Anti-BDNF antibody [EPR1292] (ab108319).

Primary antibody: Used ab108319 at a concentration of 1/1000.
Blocking: Used Licor blocking solution.

Lane 1: Human hippocampal tissue lysate
Lane 2: Rat hippocampal lysate
Lane 3: Mouse hippocampal lysate

Predicted band size: 15 kDa

WB-Anti-BDNF antibody [EPR1292] (ab108319)

Figure 4: WB-Anti-BDNF antibody [EPR1292] (ab108319).

Primary antibody: Used ab108319 at a concentration of 1/1000.

Lane 1: Human brain tissue lysate.
Lane 2: Mouse brain tissue lysate.
Lane 3: Rat brain tissue lysate.
Lane 4: Human hippocampus tissue lysate.
Lane 5: Rat hippocampus tissue lysate.
Lane 6: Mouse hippocampus tissue lysate.
Lane 7: Human cerebellum tissue lysate.
Lane 8: Mouse cerebellum tissue lysate.
Lane 9: Rat cerebellum tissue lysate.

Predicted band size: 15 kDa.
Detected band size: 15-45 kDa.

Key control points

In the experiment, in addition to paying attention to routine issues, special attention should be paid to the following key control points:

Sample preparation:

  1. Add enough protease inhibitor to avoid degradation of the target protein.
  2. Determine the total protein concentration of the sample through Bradford analysis, Lowry analysis, or BCA analysis.

Electrophoresis:

  1. For BDNF, please use high concentration (15%) separation gel or gradient gel for electrophoresis.

Transfer:

  1. We strongly recommend using Coomassie Brilliant Blue staining after transfer to determine if the transfer is successful.

Antibody incubation:

  1. We recommend using fresh antibodies and avoid reuse.

References

  1. Michael F Egan, Masami Kojima, Joseph H Callicott, Terry E Goldberg, Bhaskar S Kolachana, Alessandro Bertolino, Eugene Zaitsev, Bert Gold, David Goldman, Michael Dean, Bai Lu, Daniel R Weinberger. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003 Jan 24;112(2):257-69. doi: 10.1016/s0092-8674(03)00035-7.
  2. S J Mowla, H F Farhadi, S Pareek, J K Atwal, S J Morris, N G Seidah, R A Murphy. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem. 2001 Apr 20;276(16):12660-6. doi: 10.1074/jbc.M008104200. Epub 2001 Jan 10.